The QualityStocks Daily Friday, May 24th, 2019

Today's Top 3 Investment Newsletters

QualityStocks (EMES) +76.57%

StockMarketWatch (AMRWW) +59.18%

The Street (HIBB) +20.89%

The QualityStocks Daily Stock List

Blue Dolphin Energy Company (BDCO)

Small Cap Network, StockInvest, Zacks, Street Insider, Investor Village, StreetWise Reports, Stockhouse, Equity Clock, Marketbeat, Market Exclusive, and Dividend Investor reported previously on Blue Dolphin Energy Company (BDCO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Blue Dolphin Energy Company (BDCO) is mainly an independent refiner and marketer of petroleum products. The Company's chief asset is a 15,000 barrel per day (bpd) crude oil and condensate processing facility located in Nixon, Wilson County, Texas (Nixon Facility). Blue Dolphin Energy lists on the OTC Markets Group's OTCQX. The Company has its corporate office in Houston, Texas.

As part of its refinery business segment, Blue Dolphin Energy also conducts petroleum storage and terminaling operations under third-party lease agreements at the Nixon Facility. In addition, the Company owns and operates pipeline assets. Furthermore, it has leasehold interests in oil and gas properties.

In December 2015, Blue Dolphin Energy Company announced the closing of an additional $10.0 million loan facility. In December 2015, Lazarus Refining & Marketing, LLC, a wholly-owned subsidiary of Blue Dolphin Energy, closed on a $10.0 million term loan with Sovereign Bank, a Texas state bank. The Term Loan is guaranteed under the Business & Industry Guaranteed Loan Program administered by the United States Department of Agriculture Rural Development Program.

The proceeds of the Term Loan supported continued commercial development of Blue Dolphin Energy's Nixon Facility, specifically construction of an additional 300,000 barrels of petroleum storage tanks, and were used to refinance a $3.0 million bridge loan with Sovereign.

In June of 2015, Blue Dolphin Energy announced plans to expand the Nixon Facility and at the time was constructing 500,000 barrels of petroleum storage tanks at the refinery. At construction completion, the Nixon Facility's petroleum storage tank capacity surpasses 1,000,000 barrels. It provides capabilities to enhance operational flexibility and margins as a result of being able to accept a wider array of crude oil/condensate feedstocks at a lower cost and producing a broader assortment of products.

It also provides capabilities to support the Nixon Facility throughput growth of up to 30,000 barrels per day; and generate additional revenue from refined product and crude storage tank leasing to third parties.

Blue Dolphin Energy produces finished products, including jet fuel, and intermediate products, including naphtha, liquefied petroleum gas, atmospheric gas oil, and heavy oil-based mud blendstock. The Company also provides pipeline transportation services consisting of gathering and transportation of oil and natural gas for producers/shippers operating offshore in the Gulf of Mexico.

Blue Dolphin Energy Company (BDCO), closed Friday's trading session at $1.10, up 7.84%, on 129 volume with 2 trades. The average volume for the last 3 months is 1,666 and the stock's 52-week low/high is $0.14/$1.50.


Blue Eagle Lithium, Inc. (BEAG)

All Penny Stocks, Penny Stock Hub, Stock Guru, OTC Markets, Financial Buzz, Wallstreet Online, Stockwatch, Simply Wall St, and Wallet Investor reported earlier on Blue Eagle Lithium, Inc. (BEAG), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Blue Eagle Lithium, Inc. is a lithium resource exploration and development company listed on the OTCQB. It engages in identifying, evaluating, and developing early-stage lithium exploration opportunities in North America. The company was previously known as Wishbone Pet Products, Inc. It changed its name to Blue Eagle Lithium, Inc. in July of 2018. Blue Eagle Lithium is headquartered in Henderson, Nevada.

The Company's initial property is situated in Railroad Valley, Nevada, a highly prospective green-fields Petro-Lithium brine target area, which features numerous similarities to the nearby Clayton Valley and which Blue Eagle believes warrants an extensive exploration program. Blue Eagle Lithium has a 100 percent Working Interest (WI) in 250 placer claims.

The main exploration target within the Railroad Property would be more recent playa sediments, mostly within 2,000 feet (610 meters) of the valley's surface. Test wells will be drilled to provide lithologic data and lithium analysis sample.

Recently, Blue Eagle Lithium announced it received the analysis results from the detailed surface soil and water sampling programs that complement the initial encouraging baseline survey. Sixty-five sets of surface samples and 10 water samples were collected in late 2018. All have been professionally analyzed for 48 elements by ALS Global Geochemistry in Reno, Nevada (further to the initial 12 results published September 25, 2018). The results show a range of positive Lithium (Li) concentrations, many in excess of 100 ppm, in the surface deposits with a strong positive correlation between Lithium and Magnesium (Mg) presence and an inverse correlation between Lithium and Barium (Ba) presence.

Earlier this month, Blue Eagle Lithium announced that it secured an agreement to expand its existing holdings in Railroad Valley, Nevada. This agreement provides for the acquisition of an additional 1,000 acres contiguous to the Southwest portion of its present property bringing Blue Eagle's total land package in Railroad Valley to 5,000 acres (approximately 2,023 hectares).

Blue Eagle Lithium Chief Executive Officer, Mr. Rupert Ireland, said, "We've been looking to increase our acreage in Railroad Valley from the moment we started receiving positive soil sample results and we have been fortunate to find prospective land adjacent to our existing footprint. The land package is a natural fit and extension to our current land position, both in terms of access and geological theories. The additional acreage will further entrench the Company within the exciting gravity low area of interest in Railroad Valley and represents a clear example of the growth potential that remains for our Company, particularly within this region in the State of Nevada."

Blue Eagle Lithium, Inc. (BEAG), closed Friday's trading session at $1.02, up 2.00%, on 83,985 volume with 100 trades. The average volume for the last 3 months is 11,674 and the stock's 52-week low/high is $0.25/$3.50.


CCUR Holdings, Inc. (CCUR)

Stock Twits, Vintage Value Investing, Simply Wall St, Market Screener, The Street, Stockwatch, Last10k, Stocksholm, TipRanks, Zacks, MarketWatch, Seeking Alpha, Stockhouse, Insider Tracking, 4-Traders, YCharts, Value Walk, InvestorsHub, Equity Clock, and Pitch Book reported beforehand on CCUR Holdings, Inc. (CCUR), and today we report on the Company, here at the QualityStocks Daily Newsletter.

CCUR Holdings, Inc., formerly known as Concurrent Computer Corporation, changed its corporate name in January of 2018 following the sale of its former Real-Time business to Battery Ventures in May of 2017 and Content Delivery & Storage business in December of 2017. CCUR Holdings is currently pursuing business opportunities to maximize the value of its assets through the evaluation of additional operating businesses or assets for acquisition, continued development of its present real estate operations via its subsidiary Recur Holdings LLC, and continued development of its MCA business operations via its subsidiary LMCS. CCUR Holdings is based in Duluth, Georgia.

CCUR was founded in 1966. The Company's assets include its real estate operations (operated through subsidiary Recur Holdings), cash, securities held, receivables from the sale of its operating businesses held in escrow, taxes receivable, and tax assets attributable to its Net Operating Losses.

CCUR Holdings recently announced that via its newly formed subsidiary, LM Capital Solutions, LLC (LMCS), it closed on a Purchase Agreement to acquire the operating assets of LuxeMark Capital, LLC. LuxeMark operates through its syndication network to facilitate merchant cash advance (MCA) funding through connecting a network of MCA originators with syndicate participants who provide those originators with more capital by purchasing participation interests in funded MCAs. In addition, LuxeMark uses its expertise in the MCA industry to provide servicing and other administrative services to its syndicate network.

Earlier this month, CCUR Holdings reported Net Income for Q3 of 2019 of $1,411,000, or $0.16 per share. This represents an improvement from the Net Loss of $1,093,000, or $0.11 a share for the year-ago comparable period. Revenue for the quarter almost tripled on a sequential basis to $1,074,000 with Merchant Cash Advance (MCA) Income increasing to $825,000 and Interest Income on Loans increasing to $249,000. Other Interest, Dividend and Investment Income for the period totaled $1,557,000.

CCUR Holdings, Inc. (CCUR), closed Friday's trading session at $3.88, up 7.18%, on 7,987 volume with 14 trades. The average volume for the last 3 months is 5,263 and the stock's 52-week low/high is $3.00/$5.40.


Enthusiast Gaming Holdings, Inc. (EGHIF)

Street Signals, MicroSmallCap, GlobeNewswire, Stockhouse, Trading View, InvestorsHub, Stockwatch, The Street, OTC Markets, Wallet Investor, Seeking Alpha, Market Screener, and GuruFocus reported previously on Enthusiast Gaming Holdings, Inc. (EGHIF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Enthusiast Gaming Holdings, Inc. is the fastest-growing online community of video gamers. The Company has a platform of greater than 80 owned and affiliated websites. At present, it reaches more than 75 million monthly visitors with its unique and curated content and more than 50 million YouTube visitors. Established in 2014, Enthusiast Gaming Holdings lists on the OTC Markets' OTCQB. The Company is based in Toronto, Ontario.

Enthusiast Gaming focuses on building the largest network of authentic gaming enthusiasts, via events, original content, and advertising. In addition, the Company owns and operates Canada's largest gaming expo, Enthusiast Gaming Live Expo, EGLX, ( with over 55,000 people attending in 2018.

Enthusiast Gaming's innovative growth strategy adds to the website monetization potential that powers its platforms and partners. Currently, the Company is generating greater than one billion ad requests per week by way of Enthusiast Gaming Media and affiliated partners.

Enthusiast Gaming announced this past April that it has, via a wholly-owned subsidiary, signed a definitive agreement to purchase 20 percent of the issued and outstanding shares in Waveform Entertainment, Inc. for total consideration of $1,680,000. Waveform Entertainment is a leading esports broadcast and production company. It specializes in the organization of premium esports tournaments worldwide. Moreover, Enthusiast Gaming secured an irrevocable option, at its sole discretion, to acquire a 100 percent interest in Waveform.

Additionally, in April, Enthusiast Gaming Holdings announced that it closed the acquisition of 100 percent of the assets of The Sims Resource (TSR) from Generatorhallen AB and IBIBI HB, as earlier announced in its press release dated January 7, 2019. Enthusiast Gaming expects to realize the revenue of TSR beginning in Q2 2019 following the closing and integration on the Enthusiast platform.

This week, Enthusiast Gaming Holdings announced that its network of video game enthusiasts has grown to 150 million total monthly visitors. Monthly visitors across the network has doubled since Enthusiast completed its going public transaction in October of 2018. It has grown from two million monthly visitors since 2015. The increase validates the fast growth of the gaming industry and further positions Enthusiast Gaming as a leader in the space.

Enthusiast Gaming Holdings, Inc. (EGHIF), closed Friday's trading session at $1.254, up 1.93%, on 8,227 volume with 20 trades. The average volume for the last 3 months is 14,381 and the stock's 52-week low/high is $0.612/$1.36.


Generex Biotechnology Corporation (GNBT)

Wall Street Analyzer, Emerging Growth, Street Insider, Zacks, Capital Cube, Insider Tracking, Insider Financial, Stockhouse, Stockwatch, and OTC Markets reported earlier on Generex Biotechnology Corporation (GNBT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Generex Biotechnology Corporation is an integrated healthcare holding company with end-to-end solutions for patient centric care from fast diagnosis through delivery of personalized therapies. The Company is building a new type of healthcare company, which extends beyond traditional models providing support to physicians in an MSO network, and continuing relationships with patients to improve the patient experience and access to optimal care. Established in 1983 and OTCQB-listed, Generex Biotechnology is based in Miramar, Florida.

The Company's newly formed, wholly-owned subsidiary, NuGenerex Distribution Solutions (NDS), integrates Generex's MSO network with a pharmacy network, clinical diagnostic lab, durable medical equipment company (DME-IQ) and dedicated call center. Generex Biotechnology is advancing a legacy portfolio of immune-oncology assets, medical devices, and diagnostics. In addition, it is focusing on an acquisition strategy of strategic businesses that complement existing assets and provide immediate sources of revenue and working capital.

NDS and the newly acquired assets have been organized with an emphasis on enhancing the doctor/patient relationship via a single point of access for "high quality" ancillary services and patient support. Generex Biotechnology has reorganized its other subsidiary holdings as a family of "NuGenerex" companies. This includes NuGenerex Immuno-Oncology, NuGenerex Diagnostics, and NuGenerex Therapeutics, which house the historical Generex product development portfolio and new acquisitions, including the recently announced Olaregen Therapeutix, and Regentys.

Earlier in May, Generex Biotechnology announced that its wholly-owned subsidiary, NuGenerex Diagnostics LLC, filled an international order for 40,000 units of its malarial diagnostic product, The NGDx -Malaria PF/PV Cassette Test Kit, to Imres, BV, a Netherlands-based medical distribution company. NuGenerex Diagnostics is fully qualified as a diagnostic test developer and manufacturer under Food and Drug Administration (FDA) Good Manufacturing Procedures (GMP) and is certified by the International Standards Organization for the manufacture of medical devices under ISO 13485-2016 regulations.

Last week, Generex Biotechnology announced that its subsidiary, Olaregen Therapeutix, officially launched Excellagen Wound Conforming Matrix. Generex and Olaregen launched Excellagen during its debut at The Symposium on Advanced Wound Care (SAWC) in San Antonio, Texas. SAWC is the premier interdisciplinary wound care program in the U.S.

SAWC's annual gathering hosted wound care clinicians and renowned educators from the U.S. and globally and garnered more than 2,000 attendees. The 5-day event brings wound care professionals together and features more than 80 sessions across 6 dynamic tracks, covering practical approaches to wound care and the very latest developments in wound healing research.

Generex Biotechnology Corporation (GNBT), closed Friday's trading session at $1.01, off by 3.80%, on 53,850 volume with 35 trades. The average volume for the last 3 months is 50,679 and the stock's 52-week low/high is $0.088/$3.09.


GeoVax Labs, Inc. (GOVXD)

StreetWise Reports, Zacks, Street Insider, Investor Village, Stock News Now, Micro Cap Daily, OTC Markets, Stockwatch, Marketbeat, Real Investment Advice, InvestorsHub, Stockhouse, and Proactive Investors reported previously on GeoVax Labs, Inc. (GOVXD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, GeoVax Labs, Inc. is a biotechnology company developing human vaccines. The Company is developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle (MVA-VLP) based vaccine platform. GeoVax Labs current development programs are centered on preventive vaccines against HIV, Zika Virus, hemorrhagic fever viruses (Ebola, Sudan, Marburg, and Lassa), and malaria, and also therapeutic vaccines against chronic Hepatitis B infections and numerous cancers. GeoVax Labs has its head office in Smyrna, Georgia.

MVA is a large virus capable of carrying a number of vaccine antigens. On the platform, MVA expresses proteins that assemble into VLP immunogens within (in vivo) the person receiving the vaccine. The production of VLPs in the person being vaccinated mimics virus production in a natural infection, stimulating the humoral and cellular arms of the immune system to recognize, prevent, and control the target infection. The MVA-VLP derived vaccines elicit durable immune responses in the host alike to a live-attenuated virus. This is while providing the safety characteristics of a replication-defective vector.

GeoVax Labs has designed the leading preventative HIV vaccine candidate to fight against the subtype of HIV predominant in the larger commercial markets of the Americas, Western Europe, Japan, and Australia. At present, this program is undergoing human clinical trials managed by the HIV Vaccine Trials Network (HVTN) with the support of the National Institutes of Health (NIH). Additionally, the Company's HIV vaccine is part of collaborative efforts to develop an immunotherapy as a functional cure for HIV.

Last week, GeoVax Labs announced its observance of HIV Vaccine Awareness Day on May 18, 2019. HIV Vaccine Awareness Day is observed each year to recognize the many volunteers, community members, health professionals, and scientists working to develop a vaccine to prevent HIV. Furthermore, it is an opportunity to educate communities about the importance of preventive HIV vaccine research.

This week, GeoVax Labs announced that it will be engaged in corporate partnering meetings during the BIO International Convention, to take place in Philadelphia, Pennsylvania on June 3-6, 2019. The Company was selected by the National Institutes of Health (NIH) and BIO to exhibit and showcase its technology in a high-profile area of the exhibition floor branded as the Innovation Zone, dedicated to recipients of NIH SBIR/STTR grants.


GeoVax Labs, Inc. (GOVXD), closed Friday's trading session at $1.45, off by 12.12%, on 23,321 volume with 32 trades. The average volume for the last 3 months is 4,738 and the stock's 52-week low/high is $1.45/$3.59.


Intrusion, Inc. (INTZ)

Marketbeat, Street Insider, StockEarnings, Whale Wisdom, Market Screener, Insider Tracking, Investing Online, Stockhouse, Network World, Wallet Investor, InvestorPlace, Zacks, and InvestorsHub reported earlier on Intrusion, Inc. (INTZ), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Intrusion, Inc. is a worldwide provider of entity identification, high speed data mining, cybercrime and advanced persistent threat detection products. The Company's product families include TraceCop™ for identity discovery and disclosure, and Savant™ for network data mining and advanced persistent threat detection. Intrusion is headquartered in Richardson, Texas.

The Company's products help protect critical information assets by rapidly detecting, protecting, analyzing and reporting attacks or misuse of classified, private and regulated information for government and enterprise networks. Its TraceCop is a suite of Internet monitoring and tracking products. They provide first-rate capabilities for the identification of malicious and illegal activities based on historical and current Internet usage data.

Savant is a transparent network data capture and analysis solution. It brings science into corporate decision making. The Company's solution provides real-time access and insight into an organization's own indisputable and quantifiable network data for more effective, unbiased decision making.

Intrusion also has its Secure Taps™ - Network Taps Products. It offers a suite of secure network taps that enable easy, quick, and strong deployment of any of Intrusion's network security appliances. Using a Secure Tap is the best method for deploying network appliances.

Secure Taps connects to one's network in seconds and is totally transparent to one's network. The Intrusion Secure Tap family creates a simple, secure and resilient connection into the network for one's Compliance Commander Sentry appliance. In addition, Secure Taps have no MAC or IP addresses that makes them completely transparent to the network so they cannot be attacked.

This month, Intrusion announced financial results for the quarter ended March 31, 2019. The Company's Net Income was $947,000 in Q1 2019, versus Net Income of $346,000 for Q1 2018 and Net Income of $851,000 for Q4 2018.

Revenue for Q1 2019 was $3.2 million, versus $2.3 million for Q1 2018 and $3.0 million for Q4 2018. Gross Profit Margin was 60 percent of Revenue in Q1 2019 versus 62 percent for Q1 2018 and 63 percent for Q4 2018.

Intrusion, Inc. (INTZ), closed Friday's trading session at $4.40, up 1.57%, on 8,077 volume with 40 trades. The average volume for the last 3 months is 8,160 and the stock's 52-week low/high is $1.009/$4.51.


Star Navigation Systems Group Ltd. (SNAVF)

Investing News Alerts, Speculating Stocks, The Stock Market Watch, MarketWatch, Stockhouse, Marketwired, OTC Markets, Business Insider, PennyStockHub, Jet Life Penny Stocks, High Rising Stocks, Street Insider, Wallet Investor, and Equities reported earlier on Star Navigation Systems Group Ltd. (SNAVF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Star Navigation Systems Group Ltd. owns the exclusive worldwide license to its proprietary, patented In-flight Safety Monitoring System, STAR-ISMS®. This is the heart of the STAR-A.D.S. ® System. The Company's M.M.I. Division designs and manufactures high performance, mission critical, flight deck flat panel displays for defense and commercial aviation industries globally. OTCQB-listed, Star Navigation Systems is based in Brampton, Ontario.

The Company serves commercial airlines, helicopters, and OEMs (original equipment manufacturers). In addition, it serves the military aviation search and rescue industries. Star provides hardware and software platforms. This includes the STAR-A.D.S. ™, which is real-time global tracking and monitoring systems. Platforms additionally include the STAR-MMI™, which is flat panel and LCD displays and control units.

STAR-MMI™ has developed an extensive range of AMLCD flat panel display sizes, with LED Backlights, resolutions, and orientations. These displays are found on aircraft and simulators. The Company developed the STAR-ISMS® In-flight Safety Monitoring System. This is the first system in the world to feature in-flight data monitoring and diagnostics with a real-time, secure connection between aircraft and ground. STAR-ISMS® continuously monitors selected avionics systems on the aircraft from power-on to power-off. It instantly analyzes the data, and transmits selected data and any incident alerts, by way of satellite to the operator.

Star Navigation Systems also offers STAR-ISMS-Medevac. This is a real-time telemedicine for emergency medical evacuation via air transportation. Furthermore, Star offers STAT-T.T.T. This is a satellite flight tracking and voice/text communications system.

This past January, Star Navigation Systems announced that Star and Finances Gestion & Développement SAS (FGD), the French Holding company managing Artal Technologies and Magellium signed an arm's length agreement that provides for the acquisition by Star of a majority position in SOLUTIONS ISONEO INC., a wholly-owned FGD subsidiary located in Montreal. No finder's fees were paid. Star will undertake full operational management of the company, to be renamed STAR-ISONEO, Inc.

Last month, Star Navigation Systems announced that it and its recently acquired subsidiary Solutions Isoneo, Inc. and Centre Hospitalier Universitaire Sainte-Justine, signed a cooperation agreement for the Emergency Medical Services (EMS) markets. This will enable them to provide real-time monitoring of patients while in transit on the ground or in the air.

Additionally, in February, Star Navigation Systems Group announced that it wished to thank Ontario Premier, Mr. Doug Ford, for taking time out of his busy schedule to visit the Company's new Head Office in Brampton, Ontario. During his visit, Premier Ford was able to meet with Senior Management and staff, and tour Star's new facility. One of the highlights of the tour was a comprehensive audio-visual briefing on the Company's new MEDEVAC solutions, STAR-ISAMM™ and STAR-LSAMM™.

Star Navigation Systems Group Ltd. (SNAVF), closed Friday's trading session at $0.0409, up 0.25%, on 10,000 volume with 1 trade. The average volume for the last 3 months is 634 and the stock's 52-week low/high is $0.031/$0.109.


Bespoke Extracts, Inc. (BSPK)

Simply Wall St, Stockopedia, InvestorsHub, Wallmine, Stockhouse, Ventureline, GuruFocus, Investors Hangout, Barchart, Wallet Investor, Infront Analytics, YCharts, Market Screener, Morningstar, Market Exclusive, Marketwired, Insider Financial, and MarketWatch reported earlier on Bespoke Extracts, Inc. (BSPK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Bespoke Extracts, Inc. is a producer of high quality, flavorful, hemp-derived cannabidiol (CBD) extract products. The Company established in early 2017 to introduce a proprietary line of premium quality, all-natural CBD products in the form of tinctures and capsules for the nutraceutical and veterinary markets. Bespoke Extracts is headquartered in Sunny Isles Beach, Florida. The Company's shares trade on the OTC Markets Group's OTCQB.

The Company's products are marketed as dietary supplements and distributed through the Company's direct-to-consumers e-commerce store. Bespoke's products are produced using pure, all natural, zero-THC phytocannabinoid-rich (PCR) hemp-derived CBD. CBD is non-psychoactive. CBD (cannabidiol) is one of over 85 cannabinoids found in cannabis. CBD is present in more significant quantities in hemp than it is marijuana.

Bespoke Extracts' mission is to become one of the world's most trusted sources for premium quality, all-natural, USA-grown, hemp-derived cannabidiol (CBD) products for the nutraceutical and veterinary markets. The Company strives to use only vegan, Fair Trade Certified, and organic ingredients with fast acting benefits for anyone looking for an alternative remedy. Bespoke's farmers have been innovators in hemp agriculture, farming practices, agrotech, as well as production for generations. Bespoke's hemp is stable, high in CBD, low in THC, and resistant to pathogens and pests.

The Company's products include Sport Lemon Lime Tincture – THC Free 1500MG; CBD Manuka Honey Tincture; and CBD Bacon Flavored Pet Tincture. Moreover, products include CBD Softgel Capsules; CBD Pain Relief Cream; and CBD Isolate Powder.

Bespoke Extracts announced this past November that its Board of Directors appointed Niquana (Nikki) Noel as President and Chief Executive Officer (CEO), effective immediately. Serving Bespoke as its Operations Manager, Noel assumed day-to-day leadership of the Company and joined its Board of Directors. Noel has spent close to two decades working with privately-held and publicly-traded micro and small cap companies.

Bespoke Extracts, Inc. (BSPK), closed Friday's trading session at $0.049, up 0.72%, on 1,100 volume with 2 trades. The average volume for the last 3 months is 57,104 and the stock's 52-week low/high is $0.025/$1.77.


Exicure, Inc. (XCUR)

Insider Monkey, BioPortfolio, OTC Markets, Street Insider, MarketWatch, Business Wire, Stockopedia, Nasdaq, Morningstar, YCharts, 4-Traders, Stockwatch, GuruFocus, Simply Wall St, Penny Stock Hub, Trading View, Last10k, Adis Insight, Investors Hangout, Wallet Investor, Open Insider, Insider Mole, The Street, Interactive Brokers, Seeking Alpha and InvestorsHub reported earlier on Exicure, Inc. (XCUR), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Exicure, Inc. is a clinical stage biotechnology company listed on the OTC Markets Group's OTCQB. It is developing a new class of immunomodulatory and gene regulating drugs against validated targets. The Company's lead programs focus on oncology, inflammatory diseases, and genetic disorders. Exicure is a pioneer in gene regulatory and immunotherapeutic drugs using spherical nucleic acid (SNA™) constructs. Exicure is headquartered in Chicago, Illinois.

The Company's intellectual property (IP) portfolio includes more than 140 pending patent applications and over 55 allowed or issued patents. These filings include a range of inventions. These include fundamental nanoparticle manufacturing breakthroughs and manifold application-specific improvements.

Regarding Partnering and Licensing, Exicure's strategy is to maximize the potential of its Spherical Nucleic Acid (SNA) technology platform by way of in-house development, collaborations, and licensing. Additionally, the Company may form platform partnerships with pharmaceutical companies across numerous indications or within specific therapeutic areas.

Exicure's proprietary 3-dimensional, Spherical Nucleic Acid (SNA™) architecture unlocks the potential of therapeutic oligonucleotides in a broad array of cells and tissues. SNA constructs overcome one of the most difficult obstacles to nucleic acid therapeutics - the safe and effective delivery into cells and tissues.

The Company is employing its SNA technology to mobilize the body's natural defense against cancer. Its lead immunotherapy compound, AST-008 (initially being investigated in selected solid and hematological tumors) is a toll-like receptor 9 agonist. The design of it is to use the SNA's beneficial properties to propel a robust anti-cancer immune response.

Exicure announced this past December top-line results from a Phase 1 clinical trial evaluating XCUR17 in patients with mild-to-moderate chronic plaque psoriasis. XCUR17 is an SNA drug targeted to mRNA encoding interleukin 17 receptor alpha, or IL-17RA. IL-17RA is a key protein that propagates inflammation. In preclinical studies, XCUR17 inhibited IL-17RA expression in human skin and in psoriatic mouse models.

In February, Exicure announced that it dosed the first patient in its multicenter, open-label, Phase 1b/2 study of AST-008 combined with pembrolizumab. Enrollment in the trial is open to patients with superficial injectable tumors in advanced or metastatic solid tumor conditions. These include Merkel cell carcinoma, head and neck squamous cell carcinoma, cutaneous squamous cell carcinoma and melanoma. The primary goal of the Phase 1b dose escalation stage is to measure the safety and tolerability of the Company's AST-008 drug alone and in combination with pembrolizumab, and to ascertain a dose for the Phase 2 stage of the study.

Exicure recently provided an update on corporate progress. Dr. David Giljohann, Exicure's Chief Executive Officer, said, "We're very proud of our achievements on each of our strategic priorities for 2018. We drove two programs through Phase 1 clinical trials while laying the foundation for expanding our pipeline in neurology, rare dermatology, ophthalmology and gastroenterology. We also strengthened the management of our company and our access to capital. In the coming year, we expect to execute and advance our ongoing clinical programs, while expanding into new therapeutic areas."

Exicure, Inc. (XCUR), closed Friday's trading session at $2.85, up 2.52%, on 28,388 volume with 31 trades. The average volume for the last 3 months is 26,538 and the stock's 52-week low/high is $2.00/$6.50.


Great Bear Resources Ltd. (GTBDF)

Proactive Investors, Penny Stock Tweets, Connecting Investor, Gold Stock Data, Stockhouse, Capital Cube, Stock Digest, MoneyShow, Market Screener, Wallet Investor, The Stock Market Watch, Dividend Investor, InvestorsHub, Wallmine, Junior Mining Network, Bitcoin & Stock Journal, Streetwise Reports - The Gold Report, Trading View, MarketWatch, Seeking Alpha, Investors Hangout, Investing News, Street Insider, Resource World, Morningstar, YCharts, The Street, Streetwise Reports, and GuruFocus reported on Great Bear Resources Ltd. (GTBDF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Great Bear Resources Ltd. is a mineral exploration company listed on the OTC Markets' OTCQB. It engages in the acquisition and exploration of mineral properties in Canada. The Company's flagship Dixie property is roughly 15 minutes' drive along Highway 105 from downtown Red Lake, Ontario. The Dixie property covers a drill and geophysically defined 10-kilometer gold mineralized structure alike to that hosting other producing gold mines in the district. Great Bear Resources has its corporate office in Vancouver, British Columbia.

Furthermore, the Company is earning a 100 percent royalty-free interest in the West Madsen, Pakwash, Dedee and Sobel properties. These cover regionally significant gold-controlling structures and prospective geology. All of Great Bear Resources' Red Lake projects are accessible year-round via existing roads. The Red Lake mining district has produced more than 30,000,000 ounces of gold. It is one of the premier mining districts in Canada.

Great Bear Resources has 100 percent ownership and no royalties on 13,000 hectares in a tightly held company. The Company holds 100 percent of 9,140 hectares prospective greenstone belts at Dixie with no royalties. Gold is confirmed along a 2.3 km strike of a 10 km target. The System is open along strike and at depth. The ongoing drill program is 30,000 meters of 150 holes, through this year.

Regarding the West Madsen Project it is an on-strike extension of Pure Gold's high-grade Madsen project. Recent expansion is 1136 hectares; 3,860 hectares for all of West Madsen. The Geophysical Survey shows two main gold targets: a prominent northeast to southwest magnetic linear and strong evidence of large-scale folding. Company plans for this year at West Madsen include geological mapping, rock sampling, prospecting, as well as drill target generation.

Last month, Great Bear Resources reported drill results from the Dixie Hinge Zone (DHZ) at its Dixie Project in the Red Lake District of Ontario. The Company discovered one of the widest near-surface occurrences of veining and alteration hosting high-grade gold reported on the project so far. Additionally, it has successfully extended the Hinge Zone at depth.

Mr. Chris Taylor, Great Bear Resources' President and Chief Executive Officer, said, "We continue to be surprised by the strength and scale of the gold system at Dixie. Our latest drilling shows the Hinge Zone vein and alteration system swells to 138 feet (42 meters) in approximate true width, includes individual veins over 45 feet (14 meters) in width, and contains multiple gold-bearing veins in 4 of the latest 8 drill holes. We will continue to drill to extend the strike length, depth, and number of gold zones at the Dixie Hinge through 2019 and 2020…"

This week, Great Bear Resources reported drill results from reconnaissance drilling to the west of the Dixie Hinge Zone (DHZ) at its Dixie Project, and the acquisition of new district properties covering additional gold mineralization targets. Two exploratory drill fences were completed 150 meters and 400 meters west of the current DHZ drilling, along the D2 fold axis interpreted to be a significant gold control, using the recently added second drill rig.

Great Bear Resources reported new low-cost, royalty-free property acquisitions adding to its strategic land positions in the Red Lake District of Ontario. These newly acquired properties will be mapped and prospected this summer, with marginal impact on Great Bear's present Dixie property exploration budget and program.

Great Bear Resources Ltd. (GTBDF), closed Friday's trading session at $2.19, up 3.70%, on 5,050 volume with 32 trades. The average volume for the last 3 months is 5,050 and the stock's 52-week low/high is $0.351/$3.089.


Tinka Resources Limited (TKRFF)

Hotstocked, Junior Mining Network, Investing News, Streetwise Reports, Canadian Insider, Wallet Investor, Dividend Investor, The Prospector News, Trading View, Northern Miner, InvestorsHub, MarketWatch, Investors Hangout, OTC Markets, 24hgold, Barchart, and Stockhouse reported previously on Tinka Resources Limited (TKRFF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Tinka Resources Limited is an exploration and development company listed on the OTC Markets. Its flagship property is the 100 percent-owned Ayawilca carbonate replacement deposit (CRD) in the zinc-lead-silver belt of central Peru (200 kilometers northeast of Lima). Tinka Resources owns 100 percent of the contiguous 150 km2 mining concessions at Ayawilca. The Company is concentrating on growing the Ayawilca Mineral Resources. Tinka Resources has its head office in Vancouver, British Columbia.

Three NI 43-101 Mineral Resources exist on the Property. The Zinc Zone and Tin Zone resources are thought to be mineable by underground methods for resource calculation purposes. The Colquipucro Silver Zone is thought to be mineable by open pit methods.

The Ayawilca Zinc Zone Inferred Mineral Resource estimate currently consists of 42.7 Mt at 6.0 % zinc, 0.2 % lead, 17 g/t silver, and 79 g/t indium. In addition, it consists of a Tin Zone Inferred Mineral Resource of 10.5 Mt at 0.63 % tin, 0.23 % copper & 12 g/t silver.

Tinka Resources has formally started a Preliminary Economic Assessment (PEA) on the Ayawilca Zinc and Tin Project in Peru. Wood (formerly Amec Foster Wheeler) in Lima, Peru, has been engaged as lead consultant to prepare the PEA. Wood is a global leader in the delivery of project, engineering and technical services to energy and industrial markets.

This past January, Tinka Resources announced that it filed an updated independent National Instrument 43-101 Technical Report (NI 43-101 Technical Report) on the Mineral Resource Estimate for the Ayawilca Property, Department of Pasco, Peru , in support of Tinka's news release dated November 26, 2018.   There are no material differences in the NI 43-101 Technical Report from the information disclosed in the News Release.

Key Highlights of the updated Mineral Resources at Ayawilca include Indicated Zinc Zone Mineral Resource of 11.7 million tonnes grading 6.9% zinc, 0.16% lead, 84 g/t indium and 15 g/t silver (8.1% zinc equivalent ZnEq), containing: Inferred Zinc Zone Mineral Resource of 45.0 million tonnes grading 5.6% zinc, 0.23% lead, 67 g/t indium and 17 g/t silver (6.7% ZnEq), containing: Inferred Tin Mineral Resource of 14.5 million tonnes grading 0.63% tin, 0.21% copper, and 18 g/t silver (0.70% tin equivalent SnEq).

At the end of February, Tinka Resources announced details of its forthcoming exploration drill program and provided an update on the Preliminary Economic Assessment (PEA) for the Ayawilca zinc project. The expectation is that an exploration drill program of up to 10,000 meters will begin next month.

Moreover, its PEA is progressing well. The expectation is that it will be completed by mid-2019. The PEA will not be impacted by the forthcoming exploration drill program. Metallurgical test work on samples containing tin is now being conducted as part of the PEA.

Tinka Resources Limited (TKRFF), closed Friday's trading session at $0.225, up 2.27%, on 2,500 volume with 5 trades. The average volume for the last 3 months is 28,358 and the stock's 52-week low/high is $0.207/$0.451.


Mentor Capital, Inc. (MNTR)

Wealth Insider Alert, Stock Profile, Promotion Stock Secrets, Laissez Faire Today, BUYINS.NET, Stocks That Move, Market Intelligence Center Alert, Investors Underground, Cancer Roll Up Strategy, Stockgoodies, StreetAuthority Daily, and Five Star Stock Picks reported previously on Mentor Capital, Inc. (MNTR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Mentor Capital, Inc. provides mezzanine financing to leaders in the cannabis arena. The Company looks to come alongside and assist larger private medical marijuana and cannabis companies and their founders in meeting their liquidity, and financial objectives, to add protection for investors, and to help incubate private cannabis companies. Mentor Capital is based in San Diego, California. The Company's shares trade on the OTC Markets Group's OTCQX.

Mentor Capital participates in the legal recreational marijuana market. Nonetheless, the Company's favored focus is medical. It looks to facilitate the application of cannabis to cancer wasting, calming seizures, Parkinson's disease, lessening ocular pressures from glaucoma, in addition to decreasing chronic pain. Mentor takes a major position in the varied members of its portfolio of participating companies. However, it leaves operating control in the hands of the cannabis company founders.

The Company's preferred involvement is with larger and private pre-IPO  (Initial Public Offering)  medical marijuana companies that it can help operationally prepare for the public market and finance, sometimes working with institutional partners looking for public liquidity. Mentor migrated to the cannabis space from front-line cancer investments.  

In February of last year, Mentor Capital announced that it extended into the Colorado cannabis market with its new investment in Pueblo West Organics, LLC. Mentor stated it would be pleased to make a series of cannabis focused investments with cannabis veteran and Pueblo Founder, Mr. Pat Leonard. Mentor Capital has set up Mentor Partner II, LLC as a channel for this purpose.

Mentor Capital's belief is that there is considerable opportunity to approach the medical marijuana and adult use market as a business-focused, high-integrity, public company providing substantially more financing to private cannabis companies. Originally, the Company was established in Silicon Valley in 1985 with $1,000 by current Chief Executive Officer, Mr. Chet Billingsley. Mentor completed dozens of early private acquisitions and the Company went public in 1996.

Mentor Capital, Inc. (MNTR), closed Friday's trading session at $0.37, up 5.41%, on 7,950 volume with 11 trades. The average volume for the last 3 months is 40,774 and the stock's 52-week low/high is $0.30/$1.149.


Namaste Technologies, Inc. (NXTTF)

InvestorsHub, Profit Confidential, OTC Markets, MarketWatch, Insider Financial, MicroCapDaily, Marketwired, Seeking Alpha, Investors Hangout, Stockhouse, Trading View, Stockhouse, Barchart, Daily Marijuana Observer, and New Cannabis Ventures reported earlier on Namaste Technologies, Inc. (NXTTF), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Namaste Technologies, Inc. is the largest online retailer for medical cannabis delivery systems internationally. The Company operates the largest global cannabis e-commerce platform with greater than 30 websites in 20-plus countries under different brands. Namaste's long-term strategy is to become a top supplier of legal cannabis products as the cannabis market is legalized in each country. OTCQB-listed, Namaste Technologies is based in Toronto, Ontario.

Namaste has majority market share in Europe and Australia. The Company has operations in the United States, the United Kingdom, Canada and Germany. Furthermore, it has opened new supply channels into developing markets. These include Brazil, Mexico, and Chile.

Through vaporizer sales and the selling of glass and pipes and other dry herb related paraphilia, the Company has a very strong channel to sell to end consumers once it is legalized worldwide. Namaste Technologies owns and operates online retail sites with a presence in many nations. The Company is a global leader in delivery systems for dry herbs, which can include medicinal cannabis where legally available.

Namaste has developed and acquired innovative technology platforms. This includes, Canada's first Health Canada compliant telemedicine application. In May of 2018, Namaste acquired a top e-commerce artificial intelligence (AI) and Machine Learning Company, Findify AB. Findify uses AI algorithms to optimize and personalize a consumer's on-site buying experience.

Namaste Technologies has acquired Cannmart, Inc. This is a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program). Through Cannmart, Namaste is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Additionally, the Company is active in product development and manufacturing. Wholly-owned subsidiary Cannmart has received its Access to Cannabis for Medical Purposes Regulations (ACMPR) Production License.

This month, Namaste Technologies announced that it entered into a share purchase agreement to acquire 49 percent of the issued and outstanding shares of Calgary, Alberta based Choklat, Inc. for $1.5 million in cash consideration. As part of this acquisition, Namaste Technologies will be appointing a member to the Board of Directors of Choklat. Choklat is a premium chocolate manufacturer. It has existing sales through its online eCommerce site and via a network of distributors throughout Canada.

Meni Morim, Interim Chief Executive Officer of Namaste Technologies, said, "Choklat is a great acquisition for us with a vast offering of existing products that can be easily infused with THC or CBD and sold as edibles. Their small batch manufacturing model is a great fit within the new proposed regulations for edible cannabis products. This transaction provides the security of supply and manufacturing for our medicinal cannabis customers and provides capacity for the recreational market in the event proposed regulations are passed."

Namaste Technologies, Inc. (NXTTF), closed Friday's trading session at $0.62, up 5.82%, on 475,226 volume with 11 trades. The average volume for the last 3 months is 890,601 and the stock's 52-week low/high is $0.362/$3.05.


The QualityStocks Company Corner

INmune Bio Inc. (NASDAQ: INMB)

The QualityStocks Daily Newsletter would like to spotlight INmune Bio Inc. (NASDAQ: INMB).

INmune Bio Inc. (NASDAQ: INMB) is a diversified clinical-stage immunology company developing novel therapies that target distinct parts of a patient's innate immune system to fight disease. Drug candidates INKmune™ and INB03 may be used to treat cancer while XPro1595 targets neuroinflammation as a cause of Alzheimer's disease. INmune Bio's product platforms utilize a precision therapy approach to promote the body's innate immune response to treat unsolved problems in medicine.

INmune Bio is the first biotechnology company to close an initial public offering (IPO) in 2019 and commence trading on The Nasdaq Capital Market. The company also received a "Part the Cloud" award from the Alzheimer's Association in 2018 which included a $1 million grant to advance INmune Bio's XPro1595 drug candidate.

INmune Bio's product pipeline targets three segments of concern:

  • Alzheimer's disease/dementia claims 5.5 million patients in the United States. INmune Bio views Alzheimer's as an immunologic disease which changes the drug discovery process, changes the way clinical trials are designed, and may provide hope for patients and caregivers.
  • Cancer residual disease which is expected to generate more than 1.7 million new cases yearly with an estimated 609,640 fatalities. INMB believe that converting resting Natural Killer ("NK") cells to primed NK cells, which kill cancerous cells on contact, is an important therapeutic strategy to help clear residual disease.
  • Resistance to immunotherapy. By preventing the proliferation and function of cells that resist immunotherapy, patients should have a stronger immune response to cancer cells and may respond better to other cancer treatments including immunotherapy and live longer.

INmune Bio Drug Candidates and Clinical Programs

INKmune is a biologic delivery system that primes a patient's resting NK cells to kill cancer. INKmune targets residual disease for patients that have completed initial cancer therapy (surgery, radiation and/or chemotherapy) and have a low burden of disease with a high risk of relapse.

In late 2019, INKmune will start enrolling patients in a phase I/II trial for women with relapsed refractory ovarian cancer. In many patients, cancer relapse after seemingly effective cancer therapy is due to a failure of the patients own NK cells to eliminate minimal residual disease ("MRD").

Using a novel mechanism of action and a precision medicine approach, INKmune therapy should enhance NK cells' ability to eliminate residual disease.

INB03 is a checkpoint inhibitor that targets myeloid derived suppressor cells ("MDSC") which can produce an immunosuppressive shield that prevents a patient's own immune system from attacking the cancer. INmune Bio is currently completing a monotherapy INB03 phase I trial in patients with advanced solid tumors. The INB03 program will transition into a combination therapy clinical program in the summer of 2019 to prepare for a phase II trial in patients resistant to checkpoint inhibitors due to increased MDSC.

Treatment with INB03 should eliminate MDSC in the tumor microenvironment to allow checkpoint inhibitors to be therapeutically effective.

XPro1595 targets the microglial immune cells of the brain that are activated in many Alzheimer's disease patients. These microglial cells are a cause of neuroinflammation that can kill nerve cells and promote synaptic dysfunction – the cause of dementia in Alzheimer's.

The three-month, phase I trial is expected to enroll 18 patients in summer of 2019. It is designed to measure traditional and novel biomarkers of inflammation in patients with mild to moderate Alzheimer's disease who have neuroinflammation. The trial is supported by a $1 million "Part the Cloud" grant from the Alzheimer's Association. Inflammation, especially chronic inflammation, is being recognized as an important part of the pathology of many diseases including cancer and Alzheimer's disease.


Dr. RJ Tesi, M.D., INmune Bio co-founder, CEO and acting chief medical officer, has been a licensed physician since 1982 and a Fellow of the American College of Surgery since 1991. He received his medical degree from Washington University School of Medicine in 1982 and has served many roles in several development-stage biotech companies focused on treatment of neurodegenerative diseases, hematologic malignancies, and other inflammatory diseases.

CFO David J. Moss co-founder, has been with the company since its formation in September 2015. He holds an MBA from Rice University and a bachelor's degree in economics from the University of California, San Diego. Moss has founded, funded and taken public various companies in a variety of industries since 1995.

Mark Lowdell, Ph.D. co-founder, has served as the chief scientific officer and chief manufacturing officer at INmune Bio since the company's formation. He is a professor of cell and tissue therapy at University College London where he has led a translational immunotherapy group since 1994. He has also been a director of cellular therapy at the Royal Free London NHS Foundation Trust. He received his Ph.D. in clinical immunology from London Hospital Medical College, University of London in 1992 and is a qualified immunopathologist.

Christopher J. Barnum is director of neuroscience at INmune Bio. Barnum is a neuroimmunologist with broad expertise across neurodegenerative and psychiatric diseases holding multiple positions in academic and industry. His focus has been on translating inflammatory therapies into clinical treatments for neurologic diseases using a biomarker-directed approach. Barnum's research has been supported by the NIH, the Michael J. Fox Foundation, and the Alzheimer's Association. He received his Ph.D. in neuroscience from Binghamton University.

INmune Bio Inc. (OTC: INMB), closed the day's trading session at $10.801, up 2.47%, on 2,500 volume with 5 trades. The average volume for the last 3 months is 28,358 and the stock's 52-week low/high is $7.00/$11.50.

Recent News


The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF)

The QualityStocks Daily Newsletter would like to spotlight The Flowr Corporation (FLWR).

Canadian cannabis cultivation firm the Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) on Thursday announced approval of the company's application to have its common shares listed on the Nasdaq Capital Market. To view the full press release, visit:

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF), a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.

Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.

Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.

Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.

In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.

Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.

Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:

  • FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
  • Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
  • Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.

Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.

Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.

The Flowr Corporation (TSX.V: FLWR), closed the day's trading session at $7.29, up 2.82%, on 535,856 volume with 832 trades. The average volume for the last 3 months is 300,182 and the stock's 52-week low/high is $2.74/$8.42.

Recent News


Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands, Inc. (CSE: GGB) (OTCQB: GGBXF) ("GGB" or the "Company") is pleased to announce that its board of directors has approved the grant of an aggregate of 595,000 restricted share units (the "RSUs") under the Company's equity incentive plan (the "Plan") to certain of its employees (the "RSU Recipients"). The RSUs will be granted to the RSU Recipients as a compensation for their services to the Company and as an incentive mechanism to foster the interest of such persons in the long-term success of the Company.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.


Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed the day's trading session at $3.0107, up 1.69%, on 222,405 volume with 324 trades. The average volume for the last 3 months is 253,288 and the stock's 52-week low/high is $1.8068/$5.205.

Recent News


Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)

The QualityStocks Daily Newsletter would like to spotlight Sproutly Canada, Inc. (SRUTF).

Sproutly Canada (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G) and Moosehead Breweries Limited, the largest and oldest beer company in Canada, recently announced an exclusive joint venture for the development and production of nonalcoholic, cannabis-infused beverages. To view the full article, visit:

Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.

To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.

This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.

Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.

Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.

Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.


Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.

President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.

Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.

Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.

Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.

Sproutly Canada, Inc. (OTCQB: SRUTF), closed the day's trading session at $0.60741, up 4.73%, on 340,432 volume with 111 trades. The average volume for the last 3 months is 802,839 and the stock's 52-week low/high is $0.189/$1.875.

Recent News


Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Florida-based biotech company Earth Science Tech Inc. (OTCQB: ETST) operates in the fields of hemp cannabinoid, nutraceutical, pharmaceutical and medical device research and development. The company's focus on strategic partnerships and becoming a global leader in the CBD sector, along with its commitment to bringing cutting-edge pharmaceutical and medical-device offerings to market, has put ETST in an intriguing position.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.50, up 3.95%, on 18,700 volume with 9 trades. The average volume for the last 3 months is 34,649 and the stock's 52-week low/high is $0.375/$2.45.

Recent News


Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P)

The QualityStocks Daily Newsletter would like to spotlight Nabis Holdings (OTC: INNPF).

Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P) was featured today in the 420 with CNW by CannabisNewsWire. As plans to legalize recreational marijuana seem to have hit a dead end, lawmakers in different New Jersey legislative committees have advanced the expansion of the medical marijuana program, marijuana criminal expungement and marijuana decriminalization bills.

Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P), dba Innovative Properties Inc., is a Canadian investment company pursuing interests in high-quality cash-flow assets in real property, securities, cryptocurrency and all branches of the cannabis sector. The company's focus on strategic revenue generation, EBITDA and growth is enshrined in its moto, "One team. One goal," and is reflected in its name: "Na bis," which is defined as, "repeat performance" or "encore."


While the Nabis' targets span numerous industries, the company aims to establish an Anchor Investment Portfolio primarily through the acquisition of majority interests in high quality U.S. cannabis assets and brands that have achieved cash flow. The company will then employ a hands-on approach to assist the investee in implementing standards and consistency to enhance their operations.

Criteria for investment targets are as follows:

  • Positive EBITDA, vertically integrated operators in limited license states with large addressable markets
  • Emphasis on operations that add material EBITDA within 12 months with enhanced access to capital and Nabis' value add approach on operations and brand consistency
  • Identifying proven operators with good expertise to add value to a consolidation strategy
  • Focused on MSOs (Multi-state Operators) with strong brand traction
  • Pharma grade cultivation, extraction, dispensaries and other addressable operations

Current Endeavors

Nabis has completed investments in five Michigan properties with Cannabis provisioning, processing and cultivation licenses. The Company has also entered into binding Letters of Intent ("LOI") to invest in vertically integrated assets in Michigan, Arizona and Washington State. The company's goal is to be invested in four to five additional states in the coming months.

Arizona – LOI to acquire full control of Organica Patient Group Inc. ("OPG") and RDF Management Group. OPG is a fully integrated medical marijuana business licensed under the provisions of the Arizona Medical Marijuana Act. Its assets include the Chino Valley MMJ Dispensary and fully established Patient Group, which since 2012 has operated as "Organica Patient Group" in Chino Valley. OPG also operates a 26,000-square-foot indoor cultivation and processing center along with a 56,600-square-foot greenhouse in Prescott Valley; has its own branded products and wholesale operations which includes distribution to more than 25% of the dispensaries in Arizona; and has exclusive manufacturing and licensing agreements with Fire Brand, Gas Extracts and Donuts Concentrate products distributed within Arizona.

Michigan – LOIs to invest in multiple strategically located properties that have or are eligible for municipal approvals for provisioning centers in Michigan. The company is currently evaluating 10 to 15 additional municipally approved locations in Michigan that would substantially increase the company's overall presence in the U.S. cannabis space.

Washington State – LOI to purchase assets from PDT Technologies LLC, including extraction and production equipment and rights to lease the current production facility in Port Townsend, Wash. The LOI includes licensing rights to produce Chong's Choice Brand CO2 Vape Cartridges, one of the leading and most recognizable brands in the cannabis space. Expansion plans include construction of a new ISO designed extraction clean room and GMP lab facility with new, highly specialized equipment with two extraction lines. The facility could produce up to 20,500 kg of cannabis concentrate on an annual basis.

Hivemind Refinery – LOI to invest in a 70% interest of Hivemind Refinery, an established line of CBD-based wellness products in the United States. The investment into Hivemind expands Nabis' investment portfolio to CBD edibles, water, drops, lotions, and other CBD wellness products across the spectrum. Nabis anticipates Hivemind will be a premium consumer CBD line to be distributed across the U.S. and Canada and will focus on products utilizing locally grown, premium CBD along with unique formulations and delivery systems.

Bloombox – binding term sheet with Momentum Ideas Co. to acquire certain assets used and marketed under the brand "Bloombox," a leading intelligent retail cannabis software platform that includes the Bloombox Software and data platform. The acquisition of Bloombox will create a dominating presence in the U.S. cannabis market, featuring an integrated ecosystem of modern, next-generation cannabis technology. Bloombox is one of the world's first standards-based cannabis software systems, enabling frictionless integration with nearly any business system or regulatory body.

Proven Management Team

CEO and Director Shay Shnet has over 20 years of experience in business and was most recently a founding partner and vice president of operations of MPX Bioceutical (CSE: MPX). While at MPX, Shnet focused on the North American cannabis space and helped build the company's portfolio of international cannabis assets. He is highly skilled in finding unique opportunities and has been directly involved with the development, branding, importing, consumer packaging and distribution of a wide variety of product lines.

President Mark Krytiuk is a very successful cannabis operator and was a founding partner of MPX. As the vice president of grow operations of MPX, he oversaw the production of medical marijuana and pharma-grade products across North America. He has been directly involved in overseeing the rapid expansion and buildout of nine facilities in three countries with budgets ranging up to $30 million. Krytiuk's experience includes consulting and working with customers to develop individual requirements for indoor and outdoor cannabis cultivation while working with federal regulators and licensing bodies to ensure compliance.

Nabis Holdings (OTC: INNPF), closed the day's trading session at $0.443, up 0.11%, on 82,798 volume with 71 trades. The average volume for the last 3 months is 186,056 and the stock's 52-week low/high is $0.392/$0.791.

Recent News

chart (CIIX)

The QualityStocks Daily Newsletter would like to spotlight (CIIX). (OTCQB: CIIX), through its wholly owned subsidiary Inc., doing business as Chinese Wellness Center ("CWC"), recently launched a Glendale, California, mall pop-up kiosk, becoming the first Chinese company to sell CBD products in the United States. To view the full article, visit:

Founded in 1999, (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website,, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site,, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. (CIIX), closed the day's trading session at $0.441875, up 3.97%, on 20,805 volume with 20 trades. The average volume for the last 3 months is 60,574 and the stock's 52-week low/high is $0.365/$1.25.

Recent News


Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)

The QualityStocks Daily Newsletter would like to spotlight Siyata Mobile Inc. (SYATF).

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF), a leading global developer and provider of cellular communications solutions, on Thursday announced that it has filed its first quarter 2019 financial results. To view the full press release, visit:

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of Push-to-Talk Over Cellular ("PTT/PoC") systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.

Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.

Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.

The company has long been an industry pioneer, delivering the world's first 3G connected vehicle device as well as the world's first 4G/LTE vehicle mounted smartphone for First Responders and commercial fleets and vehicles.

Siyata is headquartered in Montréal, Québec, Canada.

Product Portfolio

Siyata's suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.

The company's flagship product, the Uniden UV350, is the world's first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.

The Uniden UV350 is currently available through Bell Mobility, Canada's largest LTE network and PTT community. Expanding its availability, Siyata is completing network approval with two North American Tier 1 operators to launch the UV350 in the U.S. in 2019.

Management Team

CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata's parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel's leading private university, and has served as an officer in the Israel Defense Forces.

Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor's degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.

CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor's degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.

Gidi Bracha, Vice President of Technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel's leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor's degree in engineering and business management from the University of Derby.

Siyata Mobile Inc. (SYATF), closed the day's trading session at $0.3375, up 13.78%, on 205,011 volume with 39 trades. The average volume for the last 3 months is 59,364 and the stock's 52-week low/high is $0.254/$0.446.

Recent News


City View Green Holdings Inc. (CSE: CVGR)

The QualityStocks Daily Newsletter would like to spotlight City View Green Holdings Inc. (CVGR).

City View Green Holdings (CSE: CVGR) is on a mission to become a leading purveyor of medicinal and recreational cannabis that provides an exceptional customer experience. In line with this goal, CVGR has secured a master grower and expert extraction team. To view the full article, visit:

City View Green Holdings Inc.'s (CSE: CVGR) (formerly Icon Exploration Inc.) primary objective is to create a well-diversified company focused on assessing and potentially acquiring targets in the cannabis industry. Icon Exploration recently signed a formal share exchange agreement relating to its proposed acquisition of privately held City View Green (“CVG”), a vertically integrated cannabis company incorporated under the laws of Ontario, Canada. CVG’s application to Health Canada for an A6ccess to Cannabis for Medical Purposes Regulations (“ACMPR”) license is now at the in-depth review stage of the licensing process.

CVG is preparing a 40,000-square-foot growing facility near Toronto to produce pharmaceutical-grade cannabis once its ACMPR license is granted. About half of the facility will initially be outfitted with state-of-the-art LED lighting, HVAC and dehumidification systems, and automation technologies to optimize the quality, safety and consistency of cannabis production. About 4,000 square feet will be devoted to an extraction laboratory featuring an ultra-efficient CO2 supercritical extraction process with plans to include ethanol extraction technology in the future.

Another 4.3 acres remains available for future construction of up to 125,000 square feet of grow and extraction space. Production plans include producing high quality edible products, distillates, and water-soluble products for the rapidly expanding CBD-infused (cannabidiol) beverage market.


Icon and CVG have assembled a talented team that includes a Master Grower with cannabis-industry experience to manage indoor grow operations and an extraction expert whose expertise in developing and launching new products was honed while working in Washington state’s cannabis sector. Having gained experience in the Washington state market the extraction expert has a number of brand ideas and recreational cannabis products that became popular in the Washington market as well as a number of in-licensing branding opportunities available to CVG. CVG has also negotiated an agreement with a private company seeking 37 retail cannabis licenses in Alberta, Canada, that provides a reciprocal exchange of shares, product, shelf space and distribution lines. Early discussions with various entities in Europe to arrange an off-take agreement for CBD oils and extracts are also underway.

Market Opportunity

The Canadian medical cannabis market has steadily been growing with an average 10 percent increase in patients each month. Now that the Canadian federal government has legalized recreational cannabis for adult users nationwide, analysts project a compound annual growth rate of nearly 78 percent from 2018 to 2021, reaching an estimated $3 billion by 2021, ArcView Market Research reports. One study from Deloitte pegged the potential economic impact of legalized medical and recreational marijuana in Canada – including transportation, licensing fees and security – at more than $22 billion over the coming years. Health Canada’s most recent data show that sales of cannabis extracts grew 961 percent in the second quarter of 2017, compared to an 89 percent increase in growth of dried cannabis during the same period.

City View Green Holdings Inc. (CSE: CVGR), closed the day's trading session at $0.115, up 4.55%, on 39,720 volume with 9 trades. The average volume for the last 3 months is 345,056 and the stock's 52-week low/high is $0.095/$0.465.

Recent News


The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) this morning announced that it has secured a cannabis supply agreement with Alberta Gaming, Liquor & Cannabis ("AGLC"), which will further expand its Western Canadian footprint. To view the full press release, visit: Also today, the company was highlighted in the Venture Breakfast Bits, by 24/7 Market News.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $3.00, even for the day, on 517,707 volume with 717 trades. The average volume for the last 3 months is 1,156,701 and the stock's 52-week low/high is $1.607/$7.894.

Recent News


Geyser Brands Inc. (TSX.V: GYSR)

The QualityStocks Daily Newsletter would like to spotlight Geyser Brands Inc. (TSX.V: GYSR).

Consumer healthcare company Geyser Brands (TSX.V: GYSR) recently appointed Brandeavour founder and CEO Anthony Webb to provide overall brand direction and assistance in commercializing new brands for the company and its subsidiaries. To view the full article, visit:

Geyser Brands Inc. (TSX.V: GYSR) is a consumer healthcare company that builds and markets some of the world's most loved cannabis products and brands in the nutraceutical, cosmetics, food and beverage and pet sectors. Using its proprietary nanotechnology formulation, the company delivers creams, beverages, baked goods and tincture formulations with superior bioavailability and water solubility.

NanoFusion Technology

The efficacy of most hemp?products is restricted as the insoluble nature of the molecules prevents most of the product from permeating the skin or entering the body system. Geyser Brands solves this insolubility problem with an advanced delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency.

Made with all-natural materials, NanoFusion technology offers an array of advantages: enhances penetration for deeper skin penetration; improves the transport of active ingredients for site-specific targeting; delivers active ingredients across cell membranes for release within the cell; provides longer shelf-life and stability of molecules.


Geyser Brands operates a 7,000-square-foot facility in Port Coquitlam, British Columbia, where its initial cannabis cultivation generated the first revenues out of the company's cultivation license granted in October 2018. Geyser Brands is approved as a licensed producer in compliance with Health Canada standards, which allows the company to pursue its processing and sales license. Obtaining this license will enable the company to extend its products and brands into the regulated Canadian cannabis market and directly to the consumer medical market.

Geyser Brands's integrated production chain and formulation lab develops innovative products using high-quality hemp and CBD for healthy lifestyle brands while its R&D lab produces product formulations designed to enhance bio-availability of hemp and CBD and shelf stability while maintaining all-natural ingredients and ensuring premium quality.

Geyser Brands will continue to seek opportunities to invest into the research and development of unique high-quality proprietary strains and technologies that target specific health-related conditions such as pain and inflammation reduction, insomnia, digestive issues and other commonly known ailments.

Growing Portfolio

Among the brand formulations in Geyser Brand's portfolio are:

  • Apothecary all-natural Hemp Terpene Pain Cream with optimal skin permeation
  • Prohibition Cold Brew Mocha designed with water soluble hemp molecules
  • Apothecary health products created to deliver fast-acting and high bioavailability in a spray formulation
  • Baked hemp infused pet products, designed to alleviate anxiety and pain, created with NanoFusion for dosage control

Management Team

Since 2014, Geyser Brands' CEO and Co-Founder Andreas Thatcher has been a principal at Rhizome Group, an entertainment company focused on building media IP through creative and market development. He previously was a founding partner at Rhizome Capital LLC, a U.S.-based media?investment?company specializing in marketing and distribution financing, and worked in the Investment Banking industry in?London and Toronto. Thatcher holds a master's degree in economics.

CFO Barry McKnight obtained his bachelor's degree from the University of British Columbia and is a Chartered Professional Accountant and?Certified Management Accountant registered in British Columbia. McKnight has over 20 years of experience as the principal of Barry D. McKnight Inc. He formerly was also a director of Indigo Sky Capital Corp. and has been the CFO and a director of the Company since 2016 and Corporate?Secretary of the Company since 2017.

Geyser Brands's Co-Founder Brad Kersch brings a strong business background with over 20 years of experience in?successful startups and working?with Fortune 500 companies. He spent his early years in the advertising and?marketing field and went on to form Hyperware, a clothing?company that sold branded clothing to retailers across Canada?before selling to clothing giant Ocean Pacific (OP). Kersch?became the president of Shoreline Studios, Canada's largest and?oldest?studio for film and TV. In 2014 he started Solace Management Group, a hemp product company focused on pet, cosmeceutical, and nutraceutical markets. As of February 2019, Geyser Brands signed a non-binding LOI to acquire Solace Management. Upon completing the proposed Solace acquisition, Geyser Brands intends to launch into the execution phase of its plan — to take its brands global through retail and digital direct-to-consumer experiences, launching its hemp-infused cannabis brands and products in the U.S., European Union, and Asia, and its CBD-infused line of products in jurisdictions where the therapeutic ingredient is legal.

Kuldip Gill, head of Geyser Brands' R&D program, has more than 35 years of experience in the cannabis industry. Gill built the largest manufacturing facility?in the lower mainland in Surrey, British Columbia, complete with R&D, analytical and quality control labs approved by both the FDA and Health Canada. He has to date created over 3,500 formulas, most notably Lakota pain relief gel. Gill's experience and proven track record is evident in the strongly marketable formulations he has developed and sold worldwide.

Geyser Brands Inc. (TSX.V: GYSR), closed the day's trading session at $0.73, even for the day, on 500 volume with 1 trade. The average volume for the last 3 months is 8,334 and the stock's 52-week low/high is $0.61/$0.85.

Recent News


Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Petroteq Energy (TSX.V: PQE) (OTC: PQEFF) has developed an oil-extraction technology that releases heavy-oil resources hidden in oil sands and oil shale deposits in a way that doesn't harm the environment. To view the full article, visit:

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil sands exploration and production on mineral leases in Vernal, Utah, and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 2,500-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Clean Oil Recovery Technology (CORT) System.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ. PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy Chairman Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry.

“API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy Inc. (PHVAF), closed the day's trading session at $0.31, even for the day, on 117,844 volume with 56 trades. The average volume for the last 3 months is 197,584 and the stock's 52-week low/high is $0.242/$1.43.

Recent News


Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

The QualityStocks Daily Newsletter would like to spotlight Wildflower Brands Inc. (WLDFF).

Wildflower Brands Inc. (OTCQB:WLDFF) (CSE:SUN) announces the availability of a CannabisNewsAudio Broadcast titled, "Celebrity Attention Fuels Rising Press Profile of CBD." To hear the CannabisNewsAudio version, visit: To read the full editorial, visit:

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.

Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.

Gathered within the growing family of Wildflower brands are the following entities:

  • Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
  • King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
  • Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.

Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.

Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.

In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.

Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.

Core Team

William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.

CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.

Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.

Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.

Wildflower Brands Inc. (WLDFF), closed the day's trading session at $0.4946, off by 1.08%, on 9,935 volume with 8 trades. The average volume for the last 3 months is 22,807 and the stock's 52-week low/high is $0.009/$1.129.

Recent News


Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Diversified holdings company Sharing Services Global Corporation (OTCQB: SHRG) is focused on reshaping how entrepreneurs succeed. The company is accomplishing this goal by elevating a growing international network of home-based entrepreneurs, known as Elepreneurs, to generate 100 percent organic growth.

Sharing Services Global Corporation (SHRG), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRG has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services Global Corporation ’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services Global Corporation , and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services Global Corporation , at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services Global Corporation (SHRG), closed the day's trading session at $0.1701, off by 5.50%, on 7,600 volume with 3 trades. The average volume for the last 3 months is 31,129 and the stock's 52-week low/high is $0.15/$0.3944.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.